Few data from rigorous clinical trials assessing ALE for treating hypercholesterolaemia exist. Beneficial effects are reported, the evidence however is not compelling. The limited data on safety suggest only mild, transient and infrequent adverse events with the short term use of ALE. More rigorous clinical trials assessing larger patient samples over longer intervention periods are needed to establish whether ALE is an effective and safe treatment option for patients with hypercholesterolaemia.
Антон Владимирович. Такой обзор не дает права ни считать листья артишокa лекарственным препаратом, ни тем более назначать его детям. Согласно всем публикациям - это пока БАД и ничего больше.
|